nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Imiquimod—skin cancer	0.157	0.224	CbGbCtD
Rotigotine—CYP1A2—Vemurafenib—skin cancer	0.086	0.123	CbGbCtD
Rotigotine—CYP3A4—Imiquimod—skin cancer	0.0822	0.117	CbGbCtD
Rotigotine—CYP3A4—Temozolomide—skin cancer	0.0822	0.117	CbGbCtD
Rotigotine—CYP2D6—Vemurafenib—skin cancer	0.0708	0.101	CbGbCtD
Rotigotine—CYP1A2—Dacarbazine—skin cancer	0.0659	0.0941	CbGbCtD
Rotigotine—CYP3A4—Vismodegib—skin cancer	0.057	0.0814	CbGbCtD
Rotigotine—CYP3A4—Vemurafenib—skin cancer	0.045	0.0643	CbGbCtD
Rotigotine—CYP1A2—Fluorouracil—skin cancer	0.0386	0.0552	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—skin cancer	0.0155	0.0221	CbGbCtD
Rotigotine—DRD5—eyelid—skin cancer	0.0149	0.545	CbGeAlD
Rotigotine—DRD1—nerve—skin cancer	0.00304	0.111	CbGeAlD
Rotigotine—DRD2—nerve—skin cancer	0.0018	0.0656	CbGeAlD
Rotigotine—DRD5—lymphoid tissue—skin cancer	0.00117	0.0428	CbGeAlD
Rotigotine—DRD5—female reproductive system—skin cancer	0.00113	0.0413	CbGeAlD
Rotigotine—DRD3—head—skin cancer	0.00101	0.0368	CbGeAlD
Rotigotine—DRD5—head—skin cancer	0.000944	0.0345	CbGeAlD
Rotigotine—Nervous system disorder—Vemurafenib—skin cancer	0.000901	0.00331	CcSEcCtD
Rotigotine—Lethargy—Fluorouracil—skin cancer	0.000898	0.0033	CcSEcCtD
Rotigotine—Skin disorder—Vemurafenib—skin cancer	0.000892	0.00327	CcSEcCtD
Rotigotine—Ill-defined disorder—Imiquimod—skin cancer	0.000891	0.00327	CcSEcCtD
Rotigotine—Weight decreased—Bleomycin—skin cancer	0.000885	0.00325	CcSEcCtD
Rotigotine—Nausea—Vismodegib—skin cancer	0.000883	0.00324	CcSEcCtD
Rotigotine—Agitation—Imiquimod—skin cancer	0.000882	0.00324	CcSEcCtD
Rotigotine—Angioedema—Imiquimod—skin cancer	0.000877	0.00322	CcSEcCtD
Rotigotine—Malaise—Imiquimod—skin cancer	0.000866	0.00318	CcSEcCtD
Rotigotine—Breast disorder—Temozolomide—skin cancer	0.000863	0.00317	CcSEcCtD
Rotigotine—Syncope—Imiquimod—skin cancer	0.000861	0.00316	CcSEcCtD
Rotigotine—CYP1A2—nipple—skin cancer	0.000861	0.0314	CbGeAlD
Rotigotine—Hypotension—Vemurafenib—skin cancer	0.000858	0.00315	CcSEcCtD
Rotigotine—Loss of consciousness—Imiquimod—skin cancer	0.000844	0.0031	CcSEcCtD
Rotigotine—Irritability—Fluorouracil—skin cancer	0.00084	0.00308	CcSEcCtD
Rotigotine—Cough—Imiquimod—skin cancer	0.000838	0.00307	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000837	0.00307	CcSEcCtD
Rotigotine—Skin exfoliation—Docetaxel—skin cancer	0.000835	0.00307	CcSEcCtD
Rotigotine—Fluid retention—Docetaxel—skin cancer	0.000831	0.00305	CcSEcCtD
Rotigotine—Hypertension—Imiquimod—skin cancer	0.000829	0.00304	CcSEcCtD
Rotigotine—Arthralgia—Imiquimod—skin cancer	0.000817	0.003	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000812	0.00298	CcSEcCtD
Rotigotine—Discomfort—Imiquimod—skin cancer	0.000807	0.00296	CcSEcCtD
Rotigotine—Sweating increased—Temozolomide—skin cancer	0.000804	0.00295	CcSEcCtD
Rotigotine—Dry mouth—Imiquimod—skin cancer	0.000799	0.00293	CcSEcCtD
Rotigotine—Decreased appetite—Vemurafenib—skin cancer	0.000798	0.00293	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000793	0.00291	CcSEcCtD
Rotigotine—Fatigue—Vemurafenib—skin cancer	0.000792	0.00291	CcSEcCtD
Rotigotine—Nasopharyngitis—Fluorouracil—skin cancer	0.000787	0.00289	CcSEcCtD
Rotigotine—Constipation—Vemurafenib—skin cancer	0.000785	0.00288	CcSEcCtD
Rotigotine—Infection—Imiquimod—skin cancer	0.000778	0.00286	CcSEcCtD
Rotigotine—Shock—Imiquimod—skin cancer	0.000771	0.00283	CcSEcCtD
Rotigotine—Nervous system disorder—Imiquimod—skin cancer	0.000768	0.00282	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Temozolomide—skin cancer	0.000767	0.00282	CcSEcCtD
Rotigotine—Skin disorder—Imiquimod—skin cancer	0.000761	0.00279	CcSEcCtD
Rotigotine—Erectile dysfunction—Temozolomide—skin cancer	0.00076	0.00279	CcSEcCtD
Rotigotine—Hyperhidrosis—Imiquimod—skin cancer	0.000757	0.00278	CcSEcCtD
Rotigotine—Weight increased—Temozolomide—skin cancer	0.000751	0.00276	CcSEcCtD
Rotigotine—Weight decreased—Temozolomide—skin cancer	0.000747	0.00274	CcSEcCtD
Rotigotine—Anorexia—Imiquimod—skin cancer	0.000747	0.00274	CcSEcCtD
Rotigotine—Infestation NOS—Temozolomide—skin cancer	0.000736	0.0027	CcSEcCtD
Rotigotine—Infestation—Temozolomide—skin cancer	0.000736	0.0027	CcSEcCtD
Rotigotine—Depression—Temozolomide—skin cancer	0.000734	0.00269	CcSEcCtD
Rotigotine—DRD1—head—skin cancer	0.000722	0.0263	CbGeAlD
Rotigotine—Swelling—Docetaxel—skin cancer	0.00072	0.00264	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000714	0.00262	CcSEcCtD
Rotigotine—Insomnia—Imiquimod—skin cancer	0.000708	0.0026	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000707	0.00259	CcSEcCtD
Rotigotine—Paraesthesia—Imiquimod—skin cancer	0.000703	0.00258	CcSEcCtD
Rotigotine—Somnolence—Imiquimod—skin cancer	0.000696	0.00256	CcSEcCtD
Rotigotine—Sinusitis—Temozolomide—skin cancer	0.000691	0.00253	CcSEcCtD
Rotigotine—Dyspepsia—Imiquimod—skin cancer	0.00069	0.00253	CcSEcCtD
Rotigotine—Erythema—Bleomycin—skin cancer	0.000682	0.0025	CcSEcCtD
Rotigotine—Decreased appetite—Imiquimod—skin cancer	0.000681	0.0025	CcSEcCtD
Rotigotine—Hot flush—Docetaxel—skin cancer	0.000679	0.00249	CcSEcCtD
Rotigotine—Infestation—Fluorouracil—skin cancer	0.000678	0.00249	CcSEcCtD
Rotigotine—Infestation NOS—Fluorouracil—skin cancer	0.000678	0.00249	CcSEcCtD
Rotigotine—Hypersensitivity—Vemurafenib—skin cancer	0.000677	0.00248	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000676	0.00248	CcSEcCtD
Rotigotine—Fatigue—Imiquimod—skin cancer	0.000675	0.00248	CcSEcCtD
Rotigotine—Menopausal symptoms—Docetaxel—skin cancer	0.000673	0.00247	CcSEcCtD
Rotigotine—Pain—Imiquimod—skin cancer	0.00067	0.00246	CcSEcCtD
Rotigotine—Asthenia—Vemurafenib—skin cancer	0.000659	0.00242	CcSEcCtD
Rotigotine—Hallucination—Temozolomide—skin cancer	0.000657	0.00241	CcSEcCtD
Rotigotine—Oedema peripheral—Temozolomide—skin cancer	0.000651	0.00239	CcSEcCtD
Rotigotine—Pruritus—Vemurafenib—skin cancer	0.00065	0.00239	CcSEcCtD
Rotigotine—Connective tissue disorder—Temozolomide—skin cancer	0.000649	0.00238	CcSEcCtD
Rotigotine—Lethargy—Docetaxel—skin cancer	0.000648	0.00238	CcSEcCtD
Rotigotine—Feeling abnormal—Imiquimod—skin cancer	0.000646	0.00237	CcSEcCtD
Rotigotine—Visual impairment—Temozolomide—skin cancer	0.000637	0.00234	CcSEcCtD
Rotigotine—Sinusitis—Fluorouracil—skin cancer	0.000636	0.00234	CcSEcCtD
Rotigotine—Erythema—Dactinomycin—skin cancer	0.000636	0.00233	CcSEcCtD
Rotigotine—Ill-defined disorder—Bleomycin—skin cancer	0.000633	0.00232	CcSEcCtD
Rotigotine—Diarrhoea—Vemurafenib—skin cancer	0.000628	0.00231	CcSEcCtD
Rotigotine—Urticaria—Imiquimod—skin cancer	0.000622	0.00228	CcSEcCtD
Rotigotine—Tinnitus—Temozolomide—skin cancer	0.000616	0.00226	CcSEcCtD
Rotigotine—Malaise—Bleomycin—skin cancer	0.000615	0.00226	CcSEcCtD
Rotigotine—Dizziness—Vemurafenib—skin cancer	0.000607	0.00223	CcSEcCtD
Rotigotine—Angiopathy—Temozolomide—skin cancer	0.000599	0.0022	CcSEcCtD
Rotigotine—Immune system disorder—Temozolomide—skin cancer	0.000597	0.00219	CcSEcCtD
Rotigotine—Mediastinal disorder—Temozolomide—skin cancer	0.000595	0.00219	CcSEcCtD
Rotigotine—Cough—Bleomycin—skin cancer	0.000595	0.00218	CcSEcCtD
Rotigotine—Ill-defined disorder—Dactinomycin—skin cancer	0.00059	0.00217	CcSEcCtD
Rotigotine—Vomiting—Vemurafenib—skin cancer	0.000584	0.00214	CcSEcCtD
Rotigotine—Orthostatic hypotension—Docetaxel—skin cancer	0.00058	0.00213	CcSEcCtD
Rotigotine—Rash—Vemurafenib—skin cancer	0.000579	0.00213	CcSEcCtD
Rotigotine—Mental disorder—Temozolomide—skin cancer	0.000579	0.00212	CcSEcCtD
Rotigotine—Dermatitis—Vemurafenib—skin cancer	0.000579	0.00212	CcSEcCtD
Rotigotine—Hypersensitivity—Imiquimod—skin cancer	0.000577	0.00212	CcSEcCtD
Rotigotine—Headache—Vemurafenib—skin cancer	0.000575	0.00211	CcSEcCtD
Rotigotine—Malnutrition—Temozolomide—skin cancer	0.000575	0.00211	CcSEcCtD
Rotigotine—Erythema—Temozolomide—skin cancer	0.000575	0.00211	CcSEcCtD
Rotigotine—Breast disorder—Docetaxel—skin cancer	0.000574	0.00211	CcSEcCtD
Rotigotine—Discomfort—Bleomycin—skin cancer	0.000574	0.00211	CcSEcCtD
Rotigotine—Malaise—Dactinomycin—skin cancer	0.000573	0.00211	CcSEcCtD
Rotigotine—Nasopharyngitis—Docetaxel—skin cancer	0.000568	0.00208	CcSEcCtD
Rotigotine—Asthenia—Imiquimod—skin cancer	0.000562	0.00206	CcSEcCtD
Rotigotine—Confusional state—Bleomycin—skin cancer	0.000561	0.00206	CcSEcCtD
Rotigotine—Pruritus—Imiquimod—skin cancer	0.000554	0.00203	CcSEcCtD
Rotigotine—Infection—Bleomycin—skin cancer	0.000553	0.00203	CcSEcCtD
Rotigotine—Nausea—Vemurafenib—skin cancer	0.000546	0.002	CcSEcCtD
Rotigotine—Tremor—Temozolomide—skin cancer	0.000539	0.00198	CcSEcCtD
Rotigotine—Diarrhoea—Imiquimod—skin cancer	0.000536	0.00197	CcSEcCtD
Rotigotine—Discomfort—Dactinomycin—skin cancer	0.000535	0.00196	CcSEcCtD
Rotigotine—Ill-defined disorder—Temozolomide—skin cancer	0.000534	0.00196	CcSEcCtD
Rotigotine—Anorexia—Bleomycin—skin cancer	0.00053	0.00195	CcSEcCtD
Rotigotine—Erythema—Fluorouracil—skin cancer	0.00053	0.00195	CcSEcCtD
Rotigotine—Agitation—Temozolomide—skin cancer	0.000529	0.00194	CcSEcCtD
Rotigotine—Angioedema—Temozolomide—skin cancer	0.000526	0.00193	CcSEcCtD
Rotigotine—Hypotension—Bleomycin—skin cancer	0.00052	0.00191	CcSEcCtD
Rotigotine—Malaise—Temozolomide—skin cancer	0.000519	0.0019	CcSEcCtD
Rotigotine—Dizziness—Imiquimod—skin cancer	0.000518	0.0019	CcSEcCtD
Rotigotine—Vertigo—Temozolomide—skin cancer	0.000517	0.0019	CcSEcCtD
Rotigotine—Infection—Dactinomycin—skin cancer	0.000516	0.00189	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000507	0.00186	CcSEcCtD
Rotigotine—Cough—Temozolomide—skin cancer	0.000502	0.00184	CcSEcCtD
Rotigotine—Paraesthesia—Bleomycin—skin cancer	0.0005	0.00183	CcSEcCtD
Rotigotine—Weight increased—Docetaxel—skin cancer	0.0005	0.00183	CcSEcCtD
Rotigotine—Vomiting—Imiquimod—skin cancer	0.000498	0.00183	CcSEcCtD
Rotigotine—Weight decreased—Docetaxel—skin cancer	0.000497	0.00182	CcSEcCtD
Rotigotine—Hypertension—Temozolomide—skin cancer	0.000497	0.00182	CcSEcCtD
Rotigotine—Anorexia—Dactinomycin—skin cancer	0.000495	0.00182	CcSEcCtD
Rotigotine—Rash—Imiquimod—skin cancer	0.000494	0.00181	CcSEcCtD
Rotigotine—Dermatitis—Imiquimod—skin cancer	0.000493	0.00181	CcSEcCtD
Rotigotine—Headache—Imiquimod—skin cancer	0.000491	0.0018	CcSEcCtD
Rotigotine—Arthralgia—Temozolomide—skin cancer	0.00049	0.0018	CcSEcCtD
Rotigotine—Infestation—Docetaxel—skin cancer	0.000489	0.0018	CcSEcCtD
Rotigotine—Infestation NOS—Docetaxel—skin cancer	0.000489	0.0018	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000486	0.00179	CcSEcCtD
Rotigotine—Discomfort—Temozolomide—skin cancer	0.000484	0.00178	CcSEcCtD
Rotigotine—Decreased appetite—Bleomycin—skin cancer	0.000484	0.00178	CcSEcCtD
Rotigotine—Dry mouth—Temozolomide—skin cancer	0.000479	0.00176	CcSEcCtD
Rotigotine—Pain—Bleomycin—skin cancer	0.000476	0.00175	CcSEcCtD
Rotigotine—Confusional state—Temozolomide—skin cancer	0.000473	0.00174	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000473	0.00174	CcSEcCtD
Rotigotine—HTR1A—head—skin cancer	0.000472	0.0172	CbGeAlD
Rotigotine—Infection—Temozolomide—skin cancer	0.000466	0.00171	CcSEcCtD
Rotigotine—Nausea—Imiquimod—skin cancer	0.000465	0.00171	CcSEcCtD
Rotigotine—Nervous system disorder—Temozolomide—skin cancer	0.00046	0.00169	CcSEcCtD
Rotigotine—Feeling abnormal—Bleomycin—skin cancer	0.000459	0.00168	CcSEcCtD
Rotigotine—Skin disorder—Temozolomide—skin cancer	0.000456	0.00167	CcSEcCtD
Rotigotine—Hyperhidrosis—Temozolomide—skin cancer	0.000454	0.00167	CcSEcCtD
Rotigotine—Decreased appetite—Dactinomycin—skin cancer	0.000451	0.00166	CcSEcCtD
Rotigotine—Fatigue—Dactinomycin—skin cancer	0.000447	0.00164	CcSEcCtD
Rotigotine—Anorexia—Temozolomide—skin cancer	0.000447	0.00164	CcSEcCtD
Rotigotine—Discomfort—Fluorouracil—skin cancer	0.000446	0.00164	CcSEcCtD
Rotigotine—Pain—Dactinomycin—skin cancer	0.000444	0.00163	CcSEcCtD
Rotigotine—Urticaria—Bleomycin—skin cancer	0.000442	0.00162	CcSEcCtD
Rotigotine—Confusional state—Fluorouracil—skin cancer	0.000436	0.0016	CcSEcCtD
Rotigotine—Oedema peripheral—Docetaxel—skin cancer	0.000433	0.00159	CcSEcCtD
Rotigotine—Connective tissue disorder—Docetaxel—skin cancer	0.000432	0.00158	CcSEcCtD
Rotigotine—Infection—Fluorouracil—skin cancer	0.00043	0.00158	CcSEcCtD
Rotigotine—Feeling abnormal—Dactinomycin—skin cancer	0.000428	0.00157	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000428	0.00157	CcSEcCtD
Rotigotine—DRD2—head—skin cancer	0.000426	0.0156	CbGeAlD
Rotigotine—Insomnia—Temozolomide—skin cancer	0.000425	0.00156	CcSEcCtD
Rotigotine—Nervous system disorder—Fluorouracil—skin cancer	0.000424	0.00156	CcSEcCtD
Rotigotine—Visual impairment—Docetaxel—skin cancer	0.000423	0.00155	CcSEcCtD
Rotigotine—Paraesthesia—Temozolomide—skin cancer	0.000422	0.00155	CcSEcCtD
Rotigotine—Somnolence—Temozolomide—skin cancer	0.000417	0.00153	CcSEcCtD
Rotigotine—Dyspepsia—Temozolomide—skin cancer	0.000413	0.00152	CcSEcCtD
Rotigotine—Anorexia—Fluorouracil—skin cancer	0.000412	0.00151	CcSEcCtD
Rotigotine—Hypersensitivity—Bleomycin—skin cancer	0.00041	0.0015	CcSEcCtD
Rotigotine—Decreased appetite—Temozolomide—skin cancer	0.000408	0.0015	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000405	0.00149	CcSEcCtD
Rotigotine—Fatigue—Temozolomide—skin cancer	0.000405	0.00149	CcSEcCtD
Rotigotine—Hypotension—Fluorouracil—skin cancer	0.000404	0.00148	CcSEcCtD
Rotigotine—Constipation—Temozolomide—skin cancer	0.000401	0.00147	CcSEcCtD
Rotigotine—Pain—Temozolomide—skin cancer	0.000401	0.00147	CcSEcCtD
Rotigotine—Asthenia—Bleomycin—skin cancer	0.000399	0.00147	CcSEcCtD
Rotigotine—Angiopathy—Docetaxel—skin cancer	0.000399	0.00146	CcSEcCtD
Rotigotine—Immune system disorder—Docetaxel—skin cancer	0.000397	0.00146	CcSEcCtD
Rotigotine—Mediastinal disorder—Docetaxel—skin cancer	0.000396	0.00145	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000394	0.00145	CcSEcCtD
Rotigotine—Pruritus—Bleomycin—skin cancer	0.000394	0.00145	CcSEcCtD
Rotigotine—Insomnia—Fluorouracil—skin cancer	0.000391	0.00144	CcSEcCtD
Rotigotine—Paraesthesia—Fluorouracil—skin cancer	0.000388	0.00143	CcSEcCtD
Rotigotine—Feeling abnormal—Temozolomide—skin cancer	0.000387	0.00142	CcSEcCtD
Rotigotine—Mental disorder—Docetaxel—skin cancer	0.000385	0.00141	CcSEcCtD
Rotigotine—Somnolence—Fluorouracil—skin cancer	0.000385	0.00141	CcSEcCtD
Rotigotine—Erythema—Docetaxel—skin cancer	0.000383	0.0014	CcSEcCtD
Rotigotine—Malnutrition—Docetaxel—skin cancer	0.000383	0.0014	CcSEcCtD
Rotigotine—Hypersensitivity—Dactinomycin—skin cancer	0.000382	0.0014	CcSEcCtD
Rotigotine—Dyspepsia—Fluorouracil—skin cancer	0.000381	0.0014	CcSEcCtD
Rotigotine—Decreased appetite—Fluorouracil—skin cancer	0.000376	0.00138	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000373	0.00137	CcSEcCtD
Rotigotine—Urticaria—Temozolomide—skin cancer	0.000373	0.00137	CcSEcCtD
Rotigotine—Asthenia—Dactinomycin—skin cancer	0.000372	0.00137	CcSEcCtD
Rotigotine—Pain—Fluorouracil—skin cancer	0.00037	0.00136	CcSEcCtD
Rotigotine—Muscle spasms—Docetaxel—skin cancer	0.000368	0.00135	CcSEcCtD
Rotigotine—Feeling abnormal—Fluorouracil—skin cancer	0.000356	0.00131	CcSEcCtD
Rotigotine—Diarrhoea—Dactinomycin—skin cancer	0.000355	0.0013	CcSEcCtD
Rotigotine—Vomiting—Bleomycin—skin cancer	0.000354	0.0013	CcSEcCtD
Rotigotine—Rash—Bleomycin—skin cancer	0.000351	0.00129	CcSEcCtD
Rotigotine—Dermatitis—Bleomycin—skin cancer	0.000351	0.00129	CcSEcCtD
Rotigotine—Hypersensitivity—Temozolomide—skin cancer	0.000346	0.00127	CcSEcCtD
Rotigotine—Urticaria—Fluorouracil—skin cancer	0.000344	0.00126	CcSEcCtD
Rotigotine—Syncope—Docetaxel—skin cancer	0.000343	0.00126	CcSEcCtD
Rotigotine—Asthenia—Temozolomide—skin cancer	0.000337	0.00124	CcSEcCtD
Rotigotine—Loss of consciousness—Docetaxel—skin cancer	0.000336	0.00123	CcSEcCtD
Rotigotine—Cough—Docetaxel—skin cancer	0.000334	0.00123	CcSEcCtD
Rotigotine—Pruritus—Temozolomide—skin cancer	0.000332	0.00122	CcSEcCtD
Rotigotine—Nausea—Bleomycin—skin cancer	0.000331	0.00121	CcSEcCtD
Rotigotine—Hypertension—Docetaxel—skin cancer	0.00033	0.00121	CcSEcCtD
Rotigotine—Vomiting—Dactinomycin—skin cancer	0.00033	0.00121	CcSEcCtD
Rotigotine—Rash—Dactinomycin—skin cancer	0.000327	0.0012	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—skin cancer	0.000326	0.0012	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000323	0.00119	CcSEcCtD
Rotigotine—Diarrhoea—Temozolomide—skin cancer	0.000321	0.00118	CcSEcCtD
Rotigotine—Hypersensitivity—Fluorouracil—skin cancer	0.000319	0.00117	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—skin cancer	0.000318	0.00117	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—skin cancer	0.000315	0.00116	CcSEcCtD
Rotigotine—CYP3A4—female reproductive system—skin cancer	0.000312	0.0114	CbGeAlD
Rotigotine—Dizziness—Temozolomide—skin cancer	0.00031	0.00114	CcSEcCtD
Rotigotine—Infection—Docetaxel—skin cancer	0.00031	0.00114	CcSEcCtD
Rotigotine—Nausea—Dactinomycin—skin cancer	0.000308	0.00113	CcSEcCtD
Rotigotine—Shock—Docetaxel—skin cancer	0.000307	0.00113	CcSEcCtD
Rotigotine—CYP2D6—female reproductive system—skin cancer	0.000307	0.0112	CbGeAlD
Rotigotine—Nervous system disorder—Docetaxel—skin cancer	0.000306	0.00112	CcSEcCtD
Rotigotine—Pruritus—Fluorouracil—skin cancer	0.000306	0.00112	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—skin cancer	0.000303	0.00111	CcSEcCtD
Rotigotine—Vomiting—Temozolomide—skin cancer	0.000298	0.0011	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—skin cancer	0.000298	0.00109	CcSEcCtD
Rotigotine—Rash—Temozolomide—skin cancer	0.000296	0.00109	CcSEcCtD
Rotigotine—Diarrhoea—Fluorouracil—skin cancer	0.000296	0.00109	CcSEcCtD
Rotigotine—Dermatitis—Temozolomide—skin cancer	0.000296	0.00109	CcSEcCtD
Rotigotine—Headache—Temozolomide—skin cancer	0.000294	0.00108	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—skin cancer	0.000292	0.00107	CcSEcCtD
Rotigotine—Dizziness—Fluorouracil—skin cancer	0.000286	0.00105	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000284	0.00104	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—skin cancer	0.000282	0.00104	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—skin cancer	0.00028	0.00103	CcSEcCtD
Rotigotine—Nausea—Temozolomide—skin cancer	0.000279	0.00102	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—skin cancer	0.000278	0.00102	CcSEcCtD
Rotigotine—Vomiting—Fluorouracil—skin cancer	0.000275	0.00101	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—skin cancer	0.000275	0.00101	CcSEcCtD
Rotigotine—Rash—Fluorouracil—skin cancer	0.000273	0.001	CcSEcCtD
Rotigotine—Dermatitis—Fluorouracil—skin cancer	0.000272	0.001	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—skin cancer	0.000271	0.000996	CcSEcCtD
Rotigotine—Headache—Fluorouracil—skin cancer	0.000271	0.000995	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00027	0.000989	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—skin cancer	0.000269	0.000988	CcSEcCtD
Rotigotine—Constipation—Docetaxel—skin cancer	0.000267	0.00098	CcSEcCtD
Rotigotine—Pain—Docetaxel—skin cancer	0.000267	0.00098	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—skin cancer	0.000257	0.000944	CcSEcCtD
Rotigotine—Nausea—Fluorouracil—skin cancer	0.000257	0.000943	CcSEcCtD
Rotigotine—CYP2D6—head—skin cancer	0.000256	0.00935	CbGeAlD
Rotigotine—Hypersensitivity—Docetaxel—skin cancer	0.00023	0.000844	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—skin cancer	0.000224	0.000822	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—skin cancer	0.000221	0.000811	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—skin cancer	0.000214	0.000784	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—skin cancer	0.000206	0.000758	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—skin cancer	0.000198	0.000729	CcSEcCtD
Rotigotine—Rash—Docetaxel—skin cancer	0.000197	0.000722	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—skin cancer	0.000197	0.000722	CcSEcCtD
Rotigotine—Headache—Docetaxel—skin cancer	0.000196	0.000718	CcSEcCtD
Rotigotine—Nausea—Docetaxel—skin cancer	0.000185	0.000681	CcSEcCtD
